Skip to content

Effectiveness Evaluation and Clinical Promotion of Critical Care Ultrasound in Hemodynamic Monitoring of Neonatal Shock

Effectiveness Evaluation and Clinical Promotion of Critical Care Ultrasound in Hemodynamic Monitoring of Neonatal Shock

Status
Recruiting
Phases
Early Phase 1
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR2400088134
Enrollment
Unknown
Registered
2024-08-12
Start date
2022-01-01
Completion date
Unknown
Last updated
2024-08-19

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

neonatal shock

Interventions

Standard treatment group:The standard treatment group receives routine treatment, and if ultrasound evaluation is required, it is requested by the attending physician and carried out by sonographers.
ultrasound-guided group :The ultrasound-guided group, in addition to standard treatment, incorporates intensive bedside ultrasound monitoring of hemodynamic changes in the patients at 1 hour, 6 hours,

Sponsors

Maternal and Child Health Hospital of Guangxi Zhuang Autonomous Region
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: Inclusion criteria:Clinical evidence of neonatal shock-inducing factors and manifestations. Neonatal shock score = 5 points. Consent from the parents to participate in the study and sign the informed consent form. According to Practical Neonatology, the diagnosis of neonatal shock is assessed based on five aspects: skin color, circulation, limb temperature, femoral artery pulsation, and blood pressure. Each aspect is assigned a score of 0, 1, or 2, with a total score = 5 indicating neonatal shock. Based on different scores, it can be classified as mild (5 points), moderate (6-8 points), or severe (9-10 points).

Exclusion criteria

Exclusion criteria: Exclusion criteria: Newborns with congenital heart disease or hematologic disorders. Newborns with severe primary organ diseases such as heart, lung, liver, kidney, and brain. Newborns who have already received Cardiotonic or vasopressor drugs before admission. Family members who do not agree to participate in the study.

Design outcomes

Primary

MeasureTime frame
success rate of shock treatment ;shock reversal time;

Secondary

MeasureTime frame
mortality;duration of hospitalization;Lactate levels;

Countries

China

Contacts

Public ContactXiaoyan Gao

Maternal and Child Health Hospital of Guangxi Zhuang Autonomous Region

2575691727@qq.com+86 189 0771 9253

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026